Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chemotherapy

Showing results (71-80 of 3,416) with videos related to

Pageof 342
Sort By:
Chemotherapy|June 10, 2011
Evaluation of elution and mechanical properties of two injectable chemotherapeutic bone cementsJohn A Handal, Jacob F Schulz, Joshua M Pahys, et al.
Chemotherapy|February 21, 2012
DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivoTie-Zhong Yi, Jia Li, Xu Han, et al.
Chemotherapy|January 18, 2012
Platinum-based compounds for the treatment of metastatic breast cancerAli I Shamseddine, Fadi S Farhat
Chemotherapy|February 8, 2012
A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancerXiao Jun Xiang, Ling Zhang, Feng Qiu, et al.
Chemotherapy|April 9, 2011
Linezolid-resistant enterococci in Greece: epidemiological characteristicsIris Spiliopoulou, Anthi Damani, Vassiliki Chini, et al.
Chemotherapy|September 7, 2011
Interaction studies of an anticancer alkaloid, (+)-(13aS)-deoxytylophorinine, with calf thymus DNA and four repeated double-helical DNAsZhenjia Liu, Haining Lv, Hongyan Li, et al.
Chemotherapy|January 1, 1990
Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsoneM D Edstein, J R Veenendaal, K H Rieckmann
Chemotherapy|May 21, 2011
Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combinationT De Pas, G Rosati, G Spitaleri, et al.
Chemotherapy|May 21, 2011
Beyond antiangiogenesis: intratumorally injected bevacizumab plays a cisplatin-sensitizing role in squamous cell carcinomas in miceYixiang Wang, Ling Dong, Qingwei Bi, et al.
Chemotherapy|May 21, 2011
Population pharmacokinetics of a novel histone deacetylase inhibitor, cyclo{(2S)-2-amino-8-[(aminocarbonyl)hydrazono] decanoyl-1-L-tryptophyl-L-isoleucyl-(2R)-2-piperidinecarbonyl} (SD-2007), and its metabolic conversion to apicidin after intravenous injection and oral administration in ratsBeom Soo Shin, Jürgen B Bulitta, Deok Ki Hong, et al.
Pageof 342

Showing results (71-80 of 3,416) with videos related to

Sort By:
Pageof 342
Chemotherapy|June 10, 2011
Evaluation of elution and mechanical properties of two injectable chemotherapeutic bone cementsJohn A Handal, Jacob F Schulz, Joshua M Pahys, et al.
Chemotherapy|February 21, 2012
DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivoTie-Zhong Yi, Jia Li, Xu Han, et al.
Chemotherapy|January 18, 2012
Platinum-based compounds for the treatment of metastatic breast cancerAli I Shamseddine, Fadi S Farhat
Chemotherapy|February 8, 2012
A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancerXiao Jun Xiang, Ling Zhang, Feng Qiu, et al.
Chemotherapy|April 9, 2011
Linezolid-resistant enterococci in Greece: epidemiological characteristicsIris Spiliopoulou, Anthi Damani, Vassiliki Chini, et al.
Chemotherapy|September 7, 2011
Interaction studies of an anticancer alkaloid, (+)-(13aS)-deoxytylophorinine, with calf thymus DNA and four repeated double-helical DNAsZhenjia Liu, Haining Lv, Hongyan Li, et al.
Chemotherapy|January 1, 1990
Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsoneM D Edstein, J R Veenendaal, K H Rieckmann
Chemotherapy|May 21, 2011
Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combinationT De Pas, G Rosati, G Spitaleri, et al.
Chemotherapy|May 21, 2011
Beyond antiangiogenesis: intratumorally injected bevacizumab plays a cisplatin-sensitizing role in squamous cell carcinomas in miceYixiang Wang, Ling Dong, Qingwei Bi, et al.
Chemotherapy|May 21, 2011
Population pharmacokinetics of a novel histone deacetylase inhibitor, cyclo{(2S)-2-amino-8-[(aminocarbonyl)hydrazono] decanoyl-1-L-tryptophyl-L-isoleucyl-(2R)-2-piperidinecarbonyl} (SD-2007), and its metabolic conversion to apicidin after intravenous injection and oral administration in ratsBeom Soo Shin, Jürgen B Bulitta, Deok Ki Hong, et al.
Pageof 342